[{"address1": "7800 Susquehanna St.", "address2": "Suite 505", "city": "Pittsburgh", "state": "PA", "zip": "15208", "country": "United States", "phone": "412 894 1853", "website": "https://lipella.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It develops LP-10, a formulation of tacrolimus for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; LP-410, an oral liposomal formulation of tacrolimus to treat oral graft-versus-host disease; and LP-50, an intravesical formulation of immunoglobulins for the treatment of non-muscle invasive bladder cancer. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jonathan  Kaufman M.B.A., Ph.D.", "age": 58, "title": "Co-Founder, Chairman, CEO, President, Secretary & Treasurer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 233300, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.309, "open": 0.309, "dayLow": 0.309, "dayHigh": 0.309, "regularMarketPreviousClose": 0.309, "regularMarketOpen": 0.309, "regularMarketDayLow": 0.309, "regularMarketDayHigh": 0.309, "payoutRatio": 0.0, "beta": -0.013, "forwardPE": -0.0965625, "volume": 420, "regularMarketVolume": 420, "averageVolume": 11073, "averageVolume10days": 3580, "averageDailyVolume10Day": 3580, "bid": 0.309, "ask": 0.3699, "bidSize": 5000, "askSize": 13000, "marketCap": 1427838, "fiftyTwoWeekLow": 0.276, "fiftyTwoWeekHigh": 7.31, "allTimeHigh": 61.76, "allTimeLow": 0.276, "priceToSalesTrailing12Months": 3.6631613, "fiftyDayAverage": 0.4548, "twoHundredDayAverage": 1.364425, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -163848, "profitMargins": 0.0, "floatShares": 4329355, "sharesOutstanding": 4620837, "sharesShort": 100093, "sharesShortPriorMonth": 133447, "sharesShortPreviousMonthDate": 1745971200, "dateShortInterest": 1748563200, "sharesPercentSharesOut": 0.0224, "heldPercentInsiders": 0.06308, "heldPercentInstitutions": 0.013049999, "shortRatio": 3.32, "shortPercentOfFloat": 0.0235, "impliedSharesOutstanding": 4620837, "bookValue": 0.322, "priceToBook": 0.9596273, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -5329759, "trailingEps": -2.26, "forwardEps": -3.2, "lastSplitFactor": "1:8", "lastSplitDate": 1731024000, "enterpriseToRevenue": -0.42, "enterpriseToEbitda": 0.03, "52WeekChange": -0.88555557, "SandP52WeekChange": 0.13613915, "quoteType": "EQUITY", "currentPrice": 0.309, "recommendationKey": "none", "totalCash": 1855771, "totalCashPerShare": 0.402, "ebitda": -5407074, "totalDebt": 264083, "quickRatio": 2.889, "currentRatio": 3.237, "totalRevenue": 389783, "debtToEquity": 17.752, "revenuePerShare": 0.128, "returnOnAssets": -1.49946, "returnOnEquity": -3.61767, "grossProfits": -3178582, "freeCashflow": -2827184, "operatingCashflow": -4775734, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -13.879411, "financialCurrency": "USD", "symbol": "LIPO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "exchange": "PNK", "messageBoardId": "finmb_35907207", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "regularMarketTime": 1765565897, "marketState": "CLOSED", "epsTrailingTwelveMonths": -2.26, "epsForward": -3.2, "fiftyDayAverageChange": -0.14580002, "fiftyDayAverageChangePercent": -0.3205805, "twoHundredDayAverageChange": -1.0554249, "twoHundredDayAverageChangePercent": -0.77353096, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2022-12-20", "cryptoTradeable": false, "shortName": "Lipella Pharmaceuticals Inc.", "longName": "Lipella Pharmaceuticals Inc.", "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1671460200000, "regularMarketChange": 0.0, "regularMarketDayRange": "0.309 - 0.309", "fullExchangeName": "OTC Markets OTCPK", "averageDailyVolume3Month": 11073, "fiftyTwoWeekLowChange": 0.032999992, "fiftyTwoWeekLowChangePercent": 0.1195652, "fiftyTwoWeekRange": "0.276 - 7.31", "fiftyTwoWeekHighChange": -7.001, "fiftyTwoWeekHighChangePercent": -0.95772916, "fiftyTwoWeekChangePercent": -88.55556, "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.309, "displayName": "Lipella Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-12-13"}]